Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regulus Therapeutics

7.97
+0.02000.25%
Volume:427.70K
Turnover:3.39M
Market Cap:551.80M
PE:-11.02
High:7.98
Open:7.91
Low:7.88
Close:7.95
Loading ...

Novartis to Buy Regulus Therapeutics for up to $1.7 Billion

Reuters
·
30 Apr

Regulus downgraded to Hold from Buy at Canaccord

TIPRANKS
·
30 Apr

Regulus Shares Jump 134% to $7.88 After Novartis Agrees to Buy Co for up to $1.7 Bln

THOMSON REUTERS
·
30 Apr

BRIEF-Regulus Therapeutics Upon Termination Of Merger Deal Under Some Circumstances, Co To Pay Parent Termination Fee Of $27.3 Million

Reuters
·
30 Apr

Regulus Therapeutics: Upon Termination of Merger Deal Under Some Circumstances, Co to Pay Parent Termination Fee of $27.3 Mln

THOMSON REUTERS
·
30 Apr

BUZZ-Regulus Therapeutics' stock price doubles on Novartis's buyout offer

Reuters
·
30 Apr

Novartis to Acquire Regulus in $1.7B Deal

Dow Jones
·
30 Apr

Shares of Regulus Therapeutics Jump 130% to $7.77 Premarket After Novartis Agrees to Buy Co for up to $1.7 Bln

THOMSON REUTERS
·
30 Apr

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal

Reuters
·
30 Apr

Novartis to Acquire Regulus Therapeutics

MT Newswires Live
·
30 Apr

BRIEF-Regulus Therapeutics Enters Into Agreement To Be Acquired By Novartis AG

Reuters
·
30 Apr

Novartis to acquire Regulus Therapeutics and farabursen, an investigational microRNA inhibitor to treat ADPKD, the most common genetic cause of renal failure

GlobeNewswire
·
30 Apr

Regulus Therapeutics Inc - Deal Valued up to $1.7 Billion With Contingent Value Right

THOMSON REUTERS
·
30 Apr

Regulus Therapeutics Enters Into Agreement to Be Acquired by Novartis Ag

THOMSON REUTERS
·
30 Apr

Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG

PR Newswire
·
30 Apr

Should You Buy Regulus (RGLS) After Golden Cross?

Zacks
·
24 Apr

Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit

PR Newswire
·
02 Apr

Oppenheimer Reaffirms Their Buy Rating on Regulus (RGLS)

TIPRANKS
·
28 Mar

Regulus Therapeutics Inc : Wells Fargo Raises to Overweight From Equal Weight; Raises Target Price to $6 From $3

THOMSON REUTERS
·
28 Mar

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live
·
28 Mar